Literature DB >> 28867818

Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women.

Zulqarnain Baloch1,2, Nafeesa Yasmeen1, Yuanyue Li2, Wenhui Zhang1,2, Hongyu Lu1,2, Xiaomei Wu3, Xueshan Xia4, Shihua Yang1,2.   

Abstract

BACKGROUND It is important to understand the knowledge that various groups of a population have about cervical cancer and human papillomavirus (HPV) and their attitudes toward HPV vaccination, as it will ultimately influence their decision-making for or against the acceptability of vaccines and other preventive methods. This study was designed to determine the level of knowledge and awareness about cervical cancer, HPV, and the HPV vaccine among Chinese women in Yunnan province. MATERIAL AND METHODS A survey was conducted in Yunnan province by the Laboratory of Molecular Virology in collaboration with the Yunnan First People's Hospital in Feb 2015. A total of 388 women were recruited and asked to participate in a questionnaire-based interview that collected information related to their awareness and knowledge about: (1) cervical cancer, (2) HPV and HPV vaccine and willingness to have their children receive vaccination, and (3) demographic characteristics. RESULTS A total of 388 HPV-positive women were included; 300/388 (73.3%) were Han, and 88/388 (22.7%) were other ethnicities. Overall, 204/388 (52.6%) of the women were aware of cervical cancer, with a significant difference between Han women and women of other ethnic groups (168/388, 56.0% and 36/88, 40.9%; P=0.015). Overall, 26.5% of the women were aware of the role of HPV in cervical cancer; 29.0% of the Han women and 18.2% of women of other ethnic groups were aware of this role of HPV (P=0.05). The knowledge that HPV infection leads to cervical cancer was higher among Han women (29.0%) compared to women of other ethnicities (18.2%). Knowledge about the HPV vaccine was very low in all ethnic groups, but the Han women were more willing to allow their children to be vaccinated before they become sexually active. A similar difference has also been found in women from various regions. CONCLUSIONS Although level of awareness and knowledge about cervical cancer was moderate, knowledge and awareness of HPV and the HPV vaccine was very low. Targeted communication is very important among populations in which knowledge gaps exist in order to promote dialogue about the vaccine among patients and their healthcare providers.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28867818      PMCID: PMC5595099          DOI: 10.12659/msm.903370

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


Background

Cervical cancer is the 3rd most frequently detected cancer among females, with an estimated 530 000 new cases and 275 000 deaths in 2008 worldwide [1]. Developed countries have reduced the incidence and mortality rates of cervical cancer due to the wide application of cervical screening tests and vaccinations [2,3]. It is well established that infection with human papillomavirus (HPV) is a major cause (99.9%) of cervical cancer and is one of the most common sexually transmitted pathogens of the genital system. Approximately 85% of the infections and 88% of the deaths caused by cervical cancer occur in developing countries [4,5]. According to the World Health Organization (WHO) (2006) estimation, multiple factors contribute to higher cervical cancer prevalence and mortality in developing regions of the world, such as lack of awareness about cervical cancer among the people, health care workers, and policy makers, lack of cervical screening programs, and limited access to healthcare facilities [6]. It is also thought that women’s knowledge about HPV and cervical cancer is very low in many countries [7-10]. China is the largest developing country, and according to the National Health and Family Planning Commission of the People’s Republic of China, it is estimated that there are 130 000 new cervical cancer cases registered annually, and almost 30 000 women die due to disease progression [11]. However, these estimates likely underestimate the true incidence of the disease due to the low number of cervical screening facilities and the substantial number of women living in rural areas, particularly the ethnic populations, who are rarely screened for cervical cancer [12]. Furthermore, many women also fail to get cervical screening tests due to poverty, fatalistic attitude, and lack of knowledge. Although the knowledge and attitudes about cervical cancer and HPV vary among Chinese women from different regions, most women have a high level of willingness to have their children receive vaccination, with some exceptions [13,14]. Previously published studies documented findings in developed areas, but the large social and economic variations of those areas make the findings less applicable to the whole of Mainland China, particularly Yunnan province. It is important to understand the knowledge of different populations about cervical cancer and HPV and their attitudes toward HPV vaccination acceptability as it will ultimately influence their decision for or against receiving HPV vaccination. Additionally, it is also important to understand the role of socioeconomic and demographic factors because several factors, such as education and interaction with the healthcare system, greatly influence HPV knowledge and vaccine acceptability compared to other factors [15]. Yunnan, also called Dian, is located in southwest China. Since ancient times, Yunnan has served as China’s gateway to Southeast Asia and South Asia. Additionally, it is a meeting point for Eastern and Western cultures. With its distinct environmental and geographical characteristics, the social characteristics of Yunnan province are also varied. In particular, 26 state-certified ethnic populations are scattered across the remote and hilly region of Yunnan. A significant difference in HPV prevalence and its genotype distribution has already been described in various populations of Yunnan [16,17]. However, no data are currently available regarding knowledge and awareness about cervical cancer, HPV, and vaccine acceptability among Chinese women in Yunnan. Thus, this study was designed to evaluate knowledge and awareness of HPV, cervical cancer, and the HPV vaccine among various populations of women in Yunnan province.

Material and Methods

Experimental ethics

A questionnaire was developed for this study. The protocol used in this study was in accordance with the Declaration of Helsinki and was approved by the Ethics Committee at Kunming University of Science and Technology and the Center for Disease Control and Prevention (CDC) in the Yunnan province, China. Written consent was individually obtained from each participant.

Participant recruiting

A survey was conducted by the Research Center for Molecular Medicine, Kunming University of Science and Technology in collaboration with First Peoples Hospitals of Yunnan. Between January 2014 and March 2015, women who visited the outpatient department of the First People’s Hospital of Yunnan were recruited. The First People’s Hospital of Yunnan is located in the center of Kunming city, which is the largest city in Yunnan province. The population of Yunnan province is approximately 44 million people. Han are the predominant ethnic group in the Yunnan province, with a population of 29 million. In contrast, other ethnic groups are in the minority and are scattered throughout various parts of the Yunnan province with a combined population of 15 million. A copy of the questionnaire was sent to a gynecologist who worked at the Outpatient Department of the Yunnan First People’s Hospital. She consented to appoint the female doctors to collect data from each patient individually. Before starting the interview, a cover letter described the aim of the study, conveyed the guarantee of secrecy, and highlighted that the participant’s decision to participate or ignore the interview would not effect of her medical check-up. For this study, we calculated that the sample size needed to estimate that the knowledge and awareness of HPV, cervical cancer, and the HPV vaccine among various populations of women in Yunnan province as high as 50% with an error rate of 5% was 384. We expected a low response rate, and the sample size was increased to 700 HPV-infected women. The overall response rate was approximately 74.4% (521/700).

Questionnaire data and process

A 20-question questionnaire was prepared based on a review of the literature and a previously published questionnaire [14,18,19] and was designed in the Chinese language. Every participant appeared in an interview, in which a standardized questionnaire was used to collect information about socio-demographic factors, such as ethnicity, area, regional background, age, education, occupation, marital status, monthly income, their knowledge about cervical cancer, HPV, and the relationship between HPV and cervical cancer and the vaccine.

Statistical analysis

The data collected from the participants were transferred into a database, and the descriptive and inferential statistics were calculated using SPSS version 20.0 for Windows (SPSS Inc., Chicago IL). The participants were divided into subgroups based on their ethnic background and regional background in order to link cervical cancer, HPV-related knowledge, the attitudes, the behaviors, and the intentions of the participants. Chi-square tests were used to test the differences between the different groups. Awareness and knowledge about HPV, cervical cancer, and the HPV vaccine are shown as percentages. The role of various variables in the knowledge and awareness about cervical cancer and HPV were calculated by a logistic regression model. Knowledge about cervical cancer and HPV were considered independent variables and other variables, such as ethnicity, regions, education, occupation, monthly income and age, were considered independent variables. All of the independent variables were divided into 2 or more categories. All of the statistical tests were two-sided; P values <0.05 were considered statistically significant.

Results

Population characteristics

A total of 521 women participated in the study, and 133 women were excluded from the study because of inconsistencies in the information they gave. The remaining 388 were finally included in the study, and 78.9% (306/388) of the participants were from various regions of the Yunnan province, while 21.1% of the women migrated from other provinces of China. A total of 77.3% of the included women were Han, and 22.7% were other ethnicities. In addition, 28.9% of the women were come from rural areas, and 71.7% came from urban areas. Among the professions, 16.2% were farmers, 7.7% were government officials and 8.2% teachers in addition to other professions. Most of the women (82.2%) were married, and 17.8% were single. A summary of the participants’ characteristics is shown in Table 1.
Table 1

Demographic characteristics of study participants (n=388).

CharacteristicsFrequencyPercent
Ethnicity
 Han30077.3
 Others8822.7
Region
 Central14036.1
 Northeast4912.6
 Northwest4210.8
 Southeast4010.3
 Southwest359.0
 Others8221.1
Area
 Rural11028.3
 Urban27871.7
Age
 <307519.3
 31–4014838.1
 41–5013033.5
 >50359.0
Education
 Graduate12131.2
 High school9424.2
 Middle7820.1
 Primary5313.6
 Illiterate4210.8
Occupation
 Farmers6316.2
 Government307.7
 Private8221.1
 Self-employed8321.4
 Teachers328.2
 Others8020.6
 Unemployed184.6
Status
 Married31982.2
 Single6917.8
Monthly Income
 <300015539.9
 3100–50011429.4
 5100–80004110.6
 8100–100007820.1
Overall, 52.6% of the women (204/388) had knowledge about cervical cancer, and only 36.1% of the women knew that cervical cancer can be cured if it is diagnosed early. Among them, 37.9% of the women had knowledge about human papillomavirus, and almost twenty percent of the women were aware that HPV infection can be transmitted through intercourse. However, only 22.7% of women reported that genital warts are caused by infection with HPV. Only 16.2% women had knowledge about the HPV vaccine. Overall, the acceptance of the HPV vaccine was high. However, the willingness to pay for the vaccine was very low (Table 2).
Table 2

Knowledge about HPV and HPV vaccination among ethnic groups.

VariableHan (n=300)Others (n=88)P-valueOverall (n=388)
Knows about cervical cancer168 (56.0)36 (40.9)0.015204 (52.6)
Knows it can be cured by early treatment114 (38.0)26 (29.5)0.16140 (36.1)
Knows about HPV113 (37.7)34 (38.6)0.9147 (37.9)
Knows HPV can be transmitted through sex66 (22.0)13 (14.8)0.1779 (20.4)
Knows that HPV can cause genital warts67 (22.3)21 (23.9)0.7788 (22.7)
Knows that HPV infection can lead to cervical cancer87 (29.0)16 (18.2)0.05103 (26.5)
Knows about HPV vaccine52 (17.3)11 (12.5)0.3263 (16.2)
Received HPV vaccination6 (2.0)1 (1.13)1.007 (1.8)
Willing to vaccinate children254 (84.7)67 (76.1)0.01321 (82.7)
Willing to pay for vaccination90 (30.0)23 (26.1)0.5113 (29.1)

n=number of participants. Bold type indicates a significant difference (p=0.05).

At baseline, the Han women (56.0%) were significantly more aware about cervical cancer than the women of other ethnicities (40.9%). Only 38.0% of the Han and 29.5% of the women of other ethnicities had heard about cervical cancer prevention through early treatment. Surprisingly, knowledge about HPV and its role in genital warts was little higher in the women of other ethnicities than among the Han women. Only 38.6% of the women of other ethnicities and 37.7% of the Han women had knowledge about HPV, while 23.9% of the women of other ethnicities and 22.2% of the Han women knew that HPV infection leads to genital warts. However, knowledge about the role of HPV infection in cervical cancer was significantly high among the Han women compared to that of the women of other ethnicities. The baseline knowledge about cervical cancer and HPV is shown in Table 2. Knowledge about cervical cancer and HPV was higher in the central region women than for those of the Southeast, Southwest, Northeast and Northwest regions (Table 3). Most of the participants from the central region were Han, lived in an urban area, were well educated, had a higher monthly income, and had healthcare access compared to their regional counterparts. The participants from the other regions mostly belonged to other ethnicities, lived in rural areas, were more likely to be middle and primary school graduates, and had a low average (<3000) monthly income and had inadequate healthcare access.
Table 3

Knowledge about HPV and its vaccination among various regions of Yunnan.

VariableCentral (n=140)Northeast (n=49)Southeast (n=40)Southwest (n=35)Northwest (n=42)P-value
Knowledge of Cervical cancer78 (55.7)16 (32.6)19 (46.34)15 (42.8)20 (47.6)0.07
Knows it can be cured by early treatment53 (37.8)14 (29.2)15 (36.6)13 (37.14)13 (30.9)0.75
Knows about HPV43 (30.7)12 (24.5)18 (45.0)14 (40.0)15 (35.7)0.25
Knows HPV can be transmitted through sex34 (24.3)9 (18.7)8 (19.5)5 (14.3)8 (19.0)0.68
Knows HPV can cause genital warts39 (27.8)12 (25.0)8 (19.5)8 (22.8)9 (21.4)0.8
Knows HPV infection can lead to cervical cancer45 (32.1)13 (27.1)12 (29.3)6 (17.1)12 (28.6)0.48
Knowledge of vaccine21 (10.1)6 (7.06)5 (6.76)9 (6.0)7 (5.15)0.52
Received HPV vaccine6 (2.1)
Willing to vaccinate children115 (82.1)37 (75.5)32 (80.0)27 (77.1)34 (80.9)0.87
Willing to pay for vaccine40 (28.6)14 (28.6)10 (25.0)9 (25.7)13 (30.9)0.97

n=number of participants. Bold type indicates a significant difference (p=0.05).

Knowledge and acceptability toward the HPV vaccine

Knowledge about the availability of HPV vaccine was very low in both groups. However, willingness to vaccinate their children with the HPV vaccine before they become sexually active was high in both groups. Such a variation has also been observed in various regions of Yunnan province. The baseline attitudes and vaccine acceptability are shown in Table 2.

Factors related to the level of knowledge

The knowledge and awareness about cervical cancer and HPV was highly related to the socio-demographic characteristics in both groups. Women with more education had significantly better knowledge and more awareness about cervical cancer and HPV than those with less education. Furthermore, settler women had significantly higher knowledge about cervical cancer and HPV than the local women. Those who had ever been married and those with a monthly income of more than 5000 Yuan were more likely to have good knowledge and awareness about HPV and cervical cancer. Additionally, women who worked in government departments or who worked in education were more knowledgeable about HPV and cervical cancer than those in other professions in both ethnic groups (Tables 4, 5).
Table 4

Logistic regression analysis for knowledge about cervical cancer.

CharacteristicsTotalKnowledgeOR (95%CI)P-value
Ethnicity0.008*
 Han300168 (56.0)1
 Others8836 (40.9)2.48 (1.27–4.82)
Region0.006*
 Central14078 (55.7)1
 Northeast4916 (32.6)1.97 (0.86–4.51)
 Northwest4220 (47.6)0.78 (0.34–1.81)
 Others8256 (68.3)0.4 (0.2–0.79)
 Southeast4019 (47.5)1.29 (0.56–2.95)
 Southwest3515 (42.8)1.53 (0.6–3.93)
Residence0.8
 Rural11053 (48.2)1
 Urban278151 (54.3)0.92 (0.48–1.76)
Age0.026*
 <307539 (52.0)1
 31–4014888 (59.4)0.43 (0.22–0.84)
 41–5013063 (48.5)0.76 (0.38–1.52)
 >503512 (34.3)1.18 (0.44–3.17)
Education0.001*
 Graduate12189 (73.5)1
 High school9449 (52.1)2.04 (1.06–3.94)
 Middle7836 (46.1)3.45 (1.65–7.23)
 Primary5311 (20.7)12.52 (4.89–32.1)
 Illiterate4219 (45.2)2.99 (1.24–7.2)
Occupation0.20
 Farmers6328 (44.4)1
 Government sector3022 (73.3)0.73 (0.23–2.33)
 Private8238 (46.3)2.46 (0.66–9.1)
 Teachers3223 (71.9)1.89 (0.84–4.27)
 Workers8038 (47.5)1.91 (0.84–4.32)
 Others8347 (56.6)1.29 (0.56–2.97)
 No work188 (44.4)0.75 (0.24–2.33)
Status0.12
 Married319173 (54.2)1
 Single6931 (44.9)1.67 (0.87–3.21)
Monthly income0.11
 <300015572 (46.4)1
 3100–50011470 (61.4)0.59 (0.33–1.06)
 5100–80004124 (58.5)0.69 (0.3–1.58)
 8100–100007838 (48.7)1.28 (0.65–2.52)

1 – OR and P-value were obtained using logistic regression analysis model. First category serves as a reference for OR calculation by logistic regression.

Statistically significant.

Table 5

Logistic regression analysis for knowledge about HPV.

CharacteristicsTotalKnowledgeOR (95%CI)P-value
Ethnicity0.28
 Han300113 (37.7)1
 Others8834 (38.6)1.45 (0.74–2.84)
Region0.001*
 Central14043 (30.7)1
 Northeast4912 (24.5)0.8 (0.33–1.97)
 Northwest4215 (35.7)0.49 (0.20–1.19)
 Others4018 (45.0)0.22 (0.11–0.44)
 Southeast3514 (40.0)0.33 (0.14–0.79)
 Southwest8245 (54.9)0.56 (0.21–1.46)
Residence0.91
 Rural11038 (34.5)1
 Urban278109 (39.2)0.96 (0.49–1.87)
Age0.016*
 <307520 (26.7)1
 31–4014866 (44.6)0.47 (0.23–0.97)
 41–5013042 (32.3)1.12 (0.54–2.35)
 >503519 (54.3)0.53 (0.19–1.45)
Education0.001*
 Graduate12172 (59.5)1
 High school9434 (36.2)2.46 (1.29–4.7)
 Middle7823 (29.5)4.23 (1.97–9.12)
 Primary535 (9.4)19.92 (6.35–62.48)
 Illiterate4213 (30.9)3.35 (1.36–8.28)
Occupation0.54
 Farmers6317 (27.0)1
 Government sector3018 (60.0)0.64 (0.2–203)
 Private8229 (35.4)2.69 (0.64–11.22)
 Teachers3219 (59.4)1.32 (0.55–3.17)
 Workers8026 (32.5)1.25 (0.53–2.98)
 Others8333 (39.7)1.21 (0.49–2.97)
 No work185 (27.8)0.76 (0.25–2.32)
Status0.21
 Married319126 (39.5)1
 Single6921 (30.4)1.56 (0.78–3.12)
Monthly income0.21
 <300015547 (30.3)1
 3100–50011452 (45.6)0.58 (0.32–1.05)
 5100–80004119 (45.2)0.53 (0.23–1.24)
 8100–100007829 (37.2)0.87 (0.43–1.77)

1 – OR and P-value were obtained using logistic regression analysis model. First category serves as a reference for OR calculation by logistic regression.

Statistically significant.

Discussion

It is well recognized that mass immunization with HPV vaccines has the potential to reduce the incidence of cervical cancer. Although 2 prophylactic HPV vaccines have been approved in over 140 countries, these vaccines were not approved by the Chinese government due to an absence of Chinese patient clinical data [20]. In 2008, 2 WHO-recommended vaccine companies began phase III Chinese clinical trials, and it is expected that they will obtain approval very soon [21]. Considering the high variations in the knowledge and awareness about cervical cancer, HPV and the attitude toward HPV vaccine acceptance in the world, particularly in China, investigations of these parameters in various Chinese populations would be ultimately helpful for designing strategies for cervical cancer screening and for introducing the HPV vaccine in Yunnan province, China. This is the first study to evaluate the knowledge and awareness of cervical cancer, HPV, and HPV vaccine among Chinese women living in Yunnan province. It is clear that knowledge about cervical cancer (52.6%) and HPV (37.9%) is low, and specific knowledge about the HPV vaccine (16.2%) is very poor. Many studies conducted in Asian countries report that 50–85% of women were aware about cervical cancer [22,23], which is consistent with the results of the present study, in which more than half of the current study participants were also aware of cervical cancer. A low level of knowledge and awareness about HPV is consistent with the data reported from P.R. China [18] and Hong Kong [24]. A low level of HPV knowledge was also reported in developed countries, such as the UK and the USA [25,26]. Interestingly, in the present study, participants’ knowledge and awareness about HPV was higher than in previously reported studies [14,18]; however, there is still need for improvement. Additionally, the participants’ awareness was also lower than in the data reported from Australia, which showed a higher rate of HPV knowledge (51.2%) among the general population, which might be due to the large-scale promotion of HPV vaccination through electronic and print media [27]. A low level of knowledge about HPV is considered to be a major hurdle for the successful implementation HPV vaccination at the national level [28]. Thus, it is very important that high-profile and persistent public education efforts be started through electronic and print media to raise awareness about HPV infection and vaccination. There are 56 state-certified ethnic groups in China; 26 of these live in Yunnan province, and the Han group has been declared the major ethnic group, with a population of 29 million. In contrast, other ethnic groups are in the minority and are dispersed mainly in remote areas of Yunnan province, with a combined population of 15 million. Several studies reported data only from Han women and from well-developed areas, such as Beijing and Guangzhou. However, no study has considered ethnic differences in knowledge and awareness about cervical cancer, HPV, and vaccination in China. Additionally, many researchers have addressed the importance of adding ethnic categories in epidemiological studies [29,30]. In the present study, we also compared the knowledge and awareness related to cervical cancer, HPV, and the vaccine in Han and other ethnic groups. We found that the Han women had more knowledge about cervical cancer and the HPV vaccine than did women of other ethnicities. However, knowledge and awareness about HPV was the same in both groups. Our study results are in line with other studies reported in the USA and Europe that showed racial differences in knowledge about cervical cancer, HPV, and HPV vaccine [31,32]. Overall, knowledge and awareness about the HPV vaccine was very low in both ethnic groups. These observations are also concordant with the data reported from Malaysia [33], China [14], and the USA [34]. In the present study, only 26.5% of Han women and 20.4% of women of other ethnicities answered that HPV can cause cervical cancer and that it can be transfer through sexual intercourse. The vast majority of women of both ethnic groups also had little awareness about the etiological role of HPV in cervical cancer and other diseases, such as genital warts. This low level of knowledge about HPV infection-related complications is in agreement with data reported from Brazil [35,36]. Our observations indicate that greater knowledge and awareness about cervical cancer and HPV does not assure a high level of awareness about its consequences. On the basis of this widespread lack of knowledge about HPV and its consequences, we urge the initiation of a high-priority public education program about HPV infection and its consequences, which explicitly addresses the knowledge deficits among the general population, particularly in minority ethnic groups. With respect to vaccine acceptability, it is true that knowledge about the availability of the HPV vaccine is very low. Most of the participants stated that they did not get the vaccination but that they will vaccinate their children before they become sexually active if the vaccine is available. Many studies report a favorable attitude toward vaccination in China [14,18] and other countries [18,25]. Interestingly, we asked the participants if they were willing to pay for vaccination and most of the women were reluctant to do so. Yunnan is an underdeveloped province of China, and the poverty ratio is a little higher compared with the rest of China, and people in Yunnan do not have enough money to pay for HPV vaccination. On the basis of these observations, we suggest that the HPV vaccine must be introduced in Yunnan province under a government subsidy program rather than through private sectors. Our study has several limitations. First, all of the participants were HPV-positive patients. Second, Yunnan province is distinct from the rest of China due to its diverse social and geographic characteristics. Han people are the Chinese ethnic majority; they tend to have higher levels of education and to live in in urban and suburban areas, while the other ethnic groups tend to live in remote mountainous areas, have less education, and have limited access to healthcare facilities. Thus, our results may not be generalizable to the entire Chinese population.

Conclusions

In summary, we found significant ethnic and regional variation in knowledge and awareness about cervical cancer, HPV, and HPV vaccination. The Han ethnic group women had higher knowledge and awareness about cervical cancer and HPV than did other ethnic groups. Although the awareness and knowledge about cervical cancer was at a moderate level, the knowledge and awareness of HPV and HPV vaccine was very low. It is important to target communication to population groups with knowledge gaps in order to promote dialogue about the vaccine among patients and their healthcare providers. Additionally, our study also shows the importance of developing and implementing public education programs to educate women about HPV, cervical cancer, and its consequences.
  28 in total

1.  Maximizing the potential public health impact of HPV vaccines: a focus on parents.

Authors:  Jessica A Kahn
Journal:  J Adolesc Health       Date:  2007-02       Impact factor: 5.012

2.  Overcoming barriers to adherence to HPV vaccination recommendations.

Authors:  Amanda F Dempsey; Matthew M Davis
Journal:  Am J Manag Care       Date:  2006-12       Impact factor: 2.229

3.  Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.

Authors:  E D Moreira; B G Oliveira; F M Ferraz; S Costa; J O Costa Filho; G Karic
Journal:  Int J Gynecol Cancer       Date:  2006 Mar-Apr       Impact factor: 3.437

4.  Knowledge and attitudes about HPV infection, HPV vaccination, and cervical cancer among rural southeast Asian women.

Authors:  Li Ping Wong
Journal:  Int J Behav Med       Date:  2011-06

5.  Knowledge and awareness of human papillomavirus (HPV), cervical cancer and HPV vaccine among women in two distinct Nepali communities.

Authors:  Derek Christopher Johnson; Madhav Prasad Bhatta; Santosh Gurung; Shilu Aryal; Pema Lhaki; Sadeep Shrestha
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa.

Authors:  Shelley A Francis; Jennifer Nelson; Joan Liverpool; Soji Soogun; Nokuthula Mofammere; Roland J Thorpe
Journal:  Vaccine       Date:  2010-09-29       Impact factor: 3.641

7.  A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China.

Authors:  Fang-Hui Zhao; Sarah M Tiggelaar; Shang-Ying Hu; Na Zhao; Ying Hong; Mayinuer Niyazi; Xiao-Hong Gao; Li-Rong Ju; Li-Qin Zhang; Xiang-Xian Feng; Xian-Zhi Duan; Xiu-Ling Song; Jing Wang; Yun Yang; Chang-Qin Li; Jia-Hua Liu; Ji-Hong Liu; Yu-Bo Lu; Li Li; Qi Zhou; Jin-Feng Liu; Li-Na Xu; You-Lin Qiao
Journal:  Asian Pac J Cancer Prev       Date:  2012

Review 8.  Predictors of HPV vaccine acceptability: a theory-informed, systematic review.

Authors:  Noel T Brewer; Karah I Fazekas
Journal:  Prev Med       Date:  2007-06-02       Impact factor: 4.018

9.  The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon.

Authors:  P-M Tebeu; A L Major; E Rapiti; P Petignat; C Bouchardy; Z Sando; L de Bernis; L Ali; P Mhawech-Fauceglia
Journal:  Int J Gynecol Cancer       Date:  2007-09-14       Impact factor: 3.437

10.  Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study.

Authors:  Irene J Chang; Rong Huang; Wei He; Shao-Kai Zhang; Shao-Ming Wang; Fang-Hui Zhao; Jennifer S Smith; You-Lin Qiao
Journal:  BMC Public Health       Date:  2013-10-02       Impact factor: 3.295

View more
  15 in total

1.  Feasibility of a combined strategy of HPV vaccination and screening in Mexico: the FASTER-Tlalpan study experience.

Authors:  L León-Maldonado; A Cabral; B Brown; G W Ryan; A Maldonado; J Salmerón; B Allen-Leigh; E Lazcano-Ponce
Journal:  Hum Vaccin Immunother       Date:  2019-07-10       Impact factor: 3.452

Review 2.  Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.

Authors:  Li Ping Wong; Liyuan Han; Hui Li; Jinshun Zhao; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2019-07-16       Impact factor: 3.452

3.  Evaluation of Knowledge and Attitude Toward HPV and Vaccination Among Medical Staff, Medical Students, and Community Members in Fujian Province.

Authors:  Chang Yu; Lihua Chen; Guanyu Ruan; Jian An; Pengming Sun
Journal:  Risk Manag Healthc Policy       Date:  2020-08-03

4.  Lon Peptidase 2, Peroxisomal (LONP2) Contributes to Cervical Carcinogenesis via Oxidative Stress.

Authors:  Wanrong Wu; Fulin Liu; Kejia Wu; Yurou Chen; Hanshu Wu; Guo Dai; Wei Zhang
Journal:  Med Sci Monit       Date:  2018-03-04

5.  Do Male University Students Know Enough About Human Papillomavirus (HPV) to Make Informed Decisions About Vaccination?

Authors:  Shuai Wang; Bingfeng Han; Yongmei Wan; Jiang Liu; Tianshuo Zhao; Hanyu Liu; Fuqiang Cui
Journal:  Med Sci Monit       Date:  2020-06-30

6.  Cervical Cancer, Human Papillomavirus Infection, and Vaccine-Related Knowledge: Awareness in Chinese Women.

Authors:  Li Yuanyue; Zulqarnain Baloch; Li Shanshan; Nafeesa Yasmeen; Wu Xiaomei; Jamal Muhammad Khan; Xia Xueshan
Journal:  Cancer Control       Date:  2018 Jan-Dec       Impact factor: 3.302

7.  Awareness of human papillomavirus infection complications, cervical cancer, and vaccine among the Saudi population. A cross-sectional survey.

Authors:  Mazen M Almehmadi; Magdi M Salih; Ayman S Al-Hazmi
Journal:  Saudi Med J       Date:  2019-06       Impact factor: 1.484

8.  Investigating Bangladeshi Rural Women's Awareness and Knowledge of Cervical Cancer and Attitude Towards HPV Vaccination: a Community-Based Cross-Sectional Analysis.

Authors:  Rajon Banik; Shabnam Naher; Mahmudur Rahman; David Gozal
Journal:  J Cancer Educ       Date:  2022-04       Impact factor: 2.037

9.  High Expression of Ubiquitin-Specific Protease 8 (USP8) Is Associated with Poor Prognosis in Patients with Cervical Squamous Cell Carcinoma.

Authors:  Min Yan; Cuihong Zhao; Na Wei; Xiaoqian Wu; Jianli Cui; Yanling Xing
Journal:  Med Sci Monit       Date:  2018-07-16

10.  NUP210 and MicroRNA-22 Modulate Fas to Elicit HeLa Cell Cycle Arrest.

Authors:  Qiao Gu; Wenjie Hou; Huan Liu; Lijuan Shi; Zonghao Zhu; Wenfeng Ye; Xiaoyuan Ni
Journal:  Yonsei Med J       Date:  2020-05       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.